AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
JACKSONVILLE, FLA. -- A majority of privately insured women tested for chlamydia are also checked for gonorrhea, which may be unnecessary given its significantly lower incidence, according to a study presented at a conference on STD prevention sponsored by the Centers for Disease Control and Prevention.
"Gonorrhea is much more rare. Chlamydia incidence is 5%-7% versus less than 1% for gonorrhea," Thomas L. Gift, Ph.D., said in an interview at his poster presentation.
Screening of all sexually active adolescents and females 25 years or younger for chlamydia is recommended by the CDC. However, screening for gonorrhea is only recommended for those at high risk of sexually transmitted diseases.
Dr. Gift and his associate Michele K. Bohm identified 61,183 females aged 15-65 years who were tested for chlamydia, gonorrhea, or both in 2001. They searched outpatient claims in the Medstat Marketscan Database of approximately 4 million privately insured patients. They looked for current procedures terminology codes ...